HOUSTON, July 16, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that the company has submitted its pivotal cellu

DUBLIN, Ohio, July 16, 2019 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced that Stephen Mason, President of the company's Cardinal Health at-Home Solutions business, has been promoted to Chief Executive Officer of Cardinal Health's Medical segment. Mr. Mason will succeed Jon Giacomin, who will

SAN FRANCISCO, July 16, 2019 /PRNewswire/ -- Doximity, the professional medical network, today published the first comprehensive

TOKYO and BOTHELL, Wash., July 16, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa

BOSTON, July 16, 2019 /PRNewswire/ -- Biofourmis, a fast-growing global leader in digital therapeutics, has entered a research partnership with the Yale University-May

WASHINGTON, July 16, 2019 /PRNewswire/ -- Medicomp Systems, a physician-driven provider of clinically contextual patient data solutions, announced today that the United States Patent

RESEARCH TRIANGLE PARK, N.C., July 16, 2019 /PRNewswire/ -- Pappas Capital, a leading investor in early-stage life sciences companies, today announced the promotion of Kyle Rasbach, PhD, PharmD to a Managing Partner of Pappas Ventures, the firm's venture capital business. In his new role, Dr. Rasbach will help to oversee Pappas Ventures and

GERMANTOWN, Md., July 16, 2019 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on developing novel treatments for nervous system diseases, today announced a reverse stock split of its shares of common stock at a ratio of 1-for-20. The reverse stock split will become effective on Wednesday, July 17, 2019

LAVAL, QC, July 16, 2019 /PRNewswire/ - Crescita Therapeutics Inc. ("Crescita" or the "Company") (TSX: CTX) (OTC US: CRRTF), a commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions, diseases and their symptoms, today announced that the United States

Stock Market SymbolsGIB (NYSE)GIB.A (TSX)www.cgi.com/newsroom FAIRFAX, VA, July 16, 2019 /PRNewswire/ - CGI (NYSE: GIB) (TSX